Kazuhiro Chiba
Corporate Officer/Principal bij Tokyo University of Agriculture & Technology
Profiel
Kazuhiro Chiba founded Jitsubo Co., Ltd.
in 2005, where he worked as Director & Chief Scientific Officer.
Dr. Chiba also currently works at Tokyo University of Agriculture & Technology, as Vice Dean & Professor.
Dr. Chiba also formerly worked at Kewpie Corp., as Principal.
Dr. Chiba received his graduate degree from Tokyo University of Agriculture & Technology.
Actieve functies van Kazuhiro Chiba
| Bedrijven | Functie | Begin |
|---|---|---|
| Tokyo University of Agriculture & Technology | Corporate Officer/Principal | - |
Eerdere bekende functies van Kazuhiro Chiba
| Bedrijven | Functie | Einde |
|---|---|---|
| KEWPIE CORPORATION | Corporate Officer/Principal | - |
Jitsubo Co., Ltd.
 Jitsubo Co., Ltd. BiotechnologyHealth Technology Jitsubo Co., Ltd. researches, develops, and produces peptides. It operates as a peptide development company that provides solutions to patients using their proprietary technologies for manufacturing and engineering peptides. The firm specializes in peptide synthesis, which enables users to modify amino acid sequence for the creation of physical, chemical, and pharmacological properties. It also engages in development of peptide pharmaceuticals, licensing regarding active ingredient manufacturing technology for peptides, and peptide drug discovery research. The company was founded by Yusuke Kohno and Kazuhiro Chiba in 2000 and is headquartered in Tokyo, Japan. | Oprichter | - |
Opleiding van Kazuhiro Chiba
| Tokyo University of Agriculture & Technology | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| KEWPIE CORPORATION | Consumer Non-Durables |
| Bedrijven in privébezit | 1 |
|---|---|
Jitsubo Co., Ltd.
Jitsubo Co., Ltd. BiotechnologyHealth Technology Jitsubo Co., Ltd. researches, develops, and produces peptides. It operates as a peptide development company that provides solutions to patients using their proprietary technologies for manufacturing and engineering peptides. The firm specializes in peptide synthesis, which enables users to modify amino acid sequence for the creation of physical, chemical, and pharmacological properties. It also engages in development of peptide pharmaceuticals, licensing regarding active ingredient manufacturing technology for peptides, and peptide drug discovery research. The company was founded by Yusuke Kohno and Kazuhiro Chiba in 2000 and is headquartered in Tokyo, Japan. | Health Technology |
